The Centre has provided services to academic institutes, research organizations and private industries. The Centre could generate extramural funding by writing grants either independently or in collaboration with other academic institutions to various funding agencies viz. DBT, DST,ICMR,UGC and IIT-NIRRH consortia. Majority of these projects including sponsored by the industry also resulted in publications in a very good impact factor journals:

  1. Maske P, Dighe V, Vanage G. (2018) n-butylparaben exposure during perinatal period impairs fertility of the F1 generation female rats. Chemosphere. 213:114-123. (IF: 4.427)
  2. Vijaykumar T, Gondhalekar, SC. Metkari SM , Dighe VD (2018) Hematological and biochemical values of Common Marmoset (Callithrix jacchus) fed with fortified diet. Journal of Laboratory Animal Science:5: 23-26
  3. Singh D, Bhagat S, Raijiwala P, Dighe V, Vanage G.(2017) Perinatal exposure of pregnant rats to cypermethrin delays testicular descent, impairs fertility in F1 male progeny leading to developmental defects in F2 generation. Chemosphere.185:376-385. (IF: 4.427)
  4. Bachhav SS, Dighe VD, Kotak D, Devarajan PV (2017). Rifampicin Lipid-Polymer hybrid nanoparticles (LIPOMER) for enhanced Peyer’s patch uptake. Int J Pharm. ;532(1):612-622.(IF: 3.649)
  5. Bachhav SS, Dighe VD, Devarajan PV. (2018). Exploring Peyer’s Patch Uptake as a Strategy for Targeted Lung Delivery of Polymeric Rifampicin Nanoparticles. Mol Pharm. 15(10):4434-4445 (IF:4.556)
  6. Gaikwad A., Khan S., Kadam S., Kadam K., Dighe V, Shah R., Kulkarni V., Kumaraswamy R., Gajbhiye R.(2017). The CFTR gene mild variants Poly-T, TG-repeats and M470V detection in Indian men with congenital bilateral absence of vas deferens. Andrologia 50 (2) (IF: 1.458)
  7. Muke SA, Peshattivar VV, Kaikini AA, Bagle SR, Dighe V, Sathaye S (2018) Neuroprotective Effect of Coumarin Nasal Formulation: Kindling Model Assessment of Epilepsy . Frontiers in Pharmacology, 9:992 IF:4.4
  8. Badgujar PC, Selkar NA, Chandratre GA, Pawar NN, Dighe VD, Bhagat ST, Telang AG, Vanage GR. Fipronil-induced genotoxicity and DNA damage in vivo: Protective effect of vitamin E.Hum Exp Toxicol. 2016 Jul 1.
  9. Tushara V, Singh D, Dhumal RV, Vanage G, Dighe V. Bisphenol A Induced Ultrastructural Changes in Common Marmoset (Callithrix jacchus) Testes. IJMR (accepted) 2016
  10. Jain SA, Awale M, Pathak S, Vanage G, Patravale VB, Sharma S. Teratogenicity of Artemether-Clindamycin Nanostructured Lipid Carriers in Rats. Int J Toxicol. 2016 Jul;35(4):420-8.
  11. Jain MR, Giri SR, Trivedi C, Bhoi B, Rath A, Vanage G, Vyas P, Ranvir R, Patel
  12. Saroglitazar, a novel PPARα/γ agonist with predominant PPARα activity, shows lipid-lowering and insulin-sensitizing effects in preclinical models. Pharmacol Res Perspect. 2015 Jun;3 (3):e00136
  13. Shete H, Sable S, Tidke P, Selkar N, Pawar Y, Chakraborty A, De A, Vanage G, Patravale V. Mono-guanidine heterolipid based SMEDDS: A promising tool for cytosolic delivery of antineoplastics. Biomaterials. 2015 Jul; 57:116-32.
  14. Thakur M, Gupta H, Singh D, Mohanty IR, Maheswari U, Vanage G, Joshi DS. Histopathological and ultra structural effects of nanoparticles on rat testis following 90 days (Chronic study) of repeated oral administration. J Nanobiotechnology. 2014 Oct 14; 12:42.
  15. Shete HK, Selkar N, Vanage GR, Patravale VB. Tamoxifen nanostructured lipid carriers: enhanced in vivo antitumor efficacy with reduced adverse drug effects. Int J Pharm. 2014 Jul 1; 468(1-2):1-14.
  16. Soni MP, Shelkar N, Gaikwad RV, Vanage GR, Samad A, Devarajan PV. Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis. J Pharm Bioallied Sci. 2014 Jan;6(1):22-30.
  17. Jaiswal AK, Dhumal RV, Bellare JR, Vanage GR. In vivo biocompatibility evaluation of electrospun composite scaffolds by subcutaneous implantation in rat. Drug Deliv Transl Res. 2013 Dec;3(6):504-17.
  18. Jaiswal AK, Dhumal RV, Ghosh S, Chaudhari P, Nemani H, Soni VP, Vanage GR, Bellare JR. Bone healing evaluation of nanofibrous composite scaffolds in rat calvarial defects: a comparative study. J Biomed Nanotechnol. 2013 Dec;9(12):2073-85.
  19. Dhumal R, Vijaykumar T, Dighe V, Selkar N, Chawda M, Vahlia M, Vanage G. Efficacy and safety of a herbo-mineral ayurvedic formulation ‘Afrodet Plus(®)’ in male rats. J Ayurveda Integr Med. 2013 Jul;4(3):158-64.
  20. Soni MP, Mahajan MV, Dhumal RV, Bhagat S, Tiwari D, Gaikwad RV, Samad A, Devarajan PV, Vanage GR. Genotoxicity evaluation of asymmetric lipid polymer hybrid nanoparticles of doxycycline hydrochloride following intravenous administration. Drug Deliv Transl Res. 2013 Oct;3(5):421-7
  21. Dhumal R, Patil P, Selkar N, Chawda M, Vahlia M, Vanage G. Sub-chronic safety evaluation of ayurvedic immunostimulant formulation ‘immuforte’ in rats in reverse pharmacology. Toxicol Int. 2013 Jan;20(1):87-94.
  22. Tiwari D, Vanage G. Mutagenic effect of Bisphenol A on adult rat male germ cells and their fertility. Reprod Toxicol. 2013 Sep;40:60-8.
  23. Doshi T, D’souza C, Vanage G. Aberrant DNA methylation at Igf2-H19 imprinting control region in spermatozoa upon neonatal exposure to bisphenol A and its association with post implantation loss. Mol Biol Rep. 2013 Aug;40(8):4747-57.
  24. Salian-Mehta S, Doshi T, Vanage G. Exposure of neonatal rats to the endocrine disrupter Bisphenol A affects ontogenic expression pattern of testicular steroid receptors and their coregulators.J Appl Toxicol. 2014 Mar;34(3):307-18.
  25. Doshi T, D’Souza C, Dighe V, Vanage G. Effect of neonatal exposure on male rats to bisphenol A on the expression of DNA methylation machinery in the postimplantation embryo. J Biochem Mol Toxicol. 2012 Sep;26(9):337-43.
  26. Tiwari D, Kamble J, Chilgunde S, Patil P, Maru G, Kawle D, Bhartiya U, Joseph L, Vanage G. Clastogenic and mutagenic effects of bisphenol A: an endocrine disruptor. Mutat Res. 2012 Mar 18;743(1-2):83-90.
  27. Doshi T, Mehta SS, Dighe V, Balasinor N, Vanage G. Hypermethylation of estrogen receptor promoter region in adult testis of rats exposed neonatally to bisphenol A. Toxicology. 2011 Nov 18;289(2-3):74-82.
  28. Dhumal R, Soni M, Devarajan P, Samad A, Gaikwad R, Vanage G. Evaluation of safety of lipomer doxycycline hydrochloride (lipomer DH). J Biomed Nanotechnol.2011 Feb;7(1):146-7.
  29. Salian S, Doshi T, Vanage G. Perinatal exposure of rats to Bisphenol A affects fertility of male offspring–an overview. Reprod Toxicol. 2011 Apr;31(3):359-62.
  30. Kurundkar SB, Sachan N, Kodam KM, Kulkarni VM, Bodhankar SL, D’Souza S, Vanage G, Ghole VS. Novel biphenyl compound, VMNS2e, ameliorates streptozotocin-induced diabetic nephropathy in rats. J Diabetes. 2010 Dec;2(4):282-9.
  31. Dandekar PP, Jain R, Patil S, Dhumal R, Tiwari D, Sharma S, Vanage G,Patravale V.Curcumin-loaded hydrogel nanoparticles: application in anti-malarialtherapy and toxicological evaluation. J Pharm Sci. 2010 Dec;99(12):4992-5010.
  32. Dandekar P, Dhumal R, Jain R, Tiwari D, Vanage G, Patravale V. Toxicological evaluation of pH-sensitive nanoparticles of curcumin: acute, sub-acute and genotoxicity studies. Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2073-89.
  33. Salian S, Doshi T, Vanage G. Perinatal exposure of rats to Bisphenol A affects the fertility of male offspring. Life Sci. 2009 Nov 18;85(21-22):742-52. 
  34. Salian S, Doshi T, Vanage G. Neonatal exposure of male rats to Bisphenol A impairs fertility and expression of sertoli cell junctional proteins in the testis. Toxicology. 2009 Nov 9;265(1-2):56-67.
  35. More AB, Chilgunde SN, Kamble JC, Patil PS, Malshe VC, Vanage GR, Devarajan Polyethylene sebacate: genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. J Pharm Sci. 2009 Dec;98(12):4781-95.
  36. Salian S, Doshi T, Vanage G. Impairment in protein expression profile of testicular steroid receptor coregulators in male rat offspring perinatally exposed to Bisphenol A. Life Sci. 2009 Jul 3;85(1-2):11-8.